Japan Intellectual Property Rights: TRISPECIFIC BINDING MOLECULES AGAINST TUMOR-ASSOCIATED ANTIGENS AND USES THEREOF

Japan, July 1 -- NOVARTIS AG has got intellectual property rights for 'TRISPECIFIC BINDING MOLECULES AGAINST TUMOR-ASSOCIATED ANTIGENS AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2024-138929

Category (FI): C12N5/10,A61K39/395@T,A61K38/17,C12N15/63@Z,C07K16/32,A61P15/02,A61P13/02,A61P13/08,A61P1/18,A61P1/02,C07K16/46,C07K16/28,C07K16/30,C07K14/47,C07K14/705,C07K19/00,C12N15/62@Z,C12N15/13,C12N15/12,C12P21/02@C,C12P21/08,C12N1/15,C12N1/19,C12N1/21,A61P27/02,A61P11/02,A61P17/00,A61P11/04,A61P9/00,A61P11/00,A61P15/00,A61P19/08,A61P13/10,A61P1/16,A61P25/00,A61P1/04,A61P13/12,A61P35/02,A61P43/00,111,A61P43/00,105,A61K45/00,A61K39/395@L,A61P35/00,A61K39/395@N

Stage: Grant (IP right granted following substanti...